2009•Pathologie BiologieRequires access

JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: Contribution, diagnosis and therapeutic prospects

Amal Ben Moussa, Hakim‐Moulay Dehbi, S. Majdoub Fehri, Asmâa Quessar, Sellama Nadifi

Open publisher page 8 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: JAK2 V617F, Myeloproliferative Disorders, Mutation, Medicine, Polycythemia vera, Internal medicine, Genetics, Myelofibrosis

Back to paper search Browse research topics Original source

JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: Contribution, diagnosis and therapeutic prospects — Research Paper | ScholarLens